260 related articles for article (PubMed ID: 17197171)
1. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells.
Planas-Silva MD; Waltz PK
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):11-21. PubMed ID: 17197171
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation.
Hiscox S; Jiang WG; Obermeier K; Taylor K; Morgan L; Burmi R; Barrow D; Nicholson RI
Int J Cancer; 2006 Jan; 118(2):290-301. PubMed ID: 16080193
[TBL] [Abstract][Full Text] [Related]
4. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
5. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
6. The relationships between snail1 and estrogen receptor signaling in breast cancer cells.
Scherbakov AM; Andreeva OE; Shatskaya VA; Krasil'nikov MA
J Cell Biochem; 2012 Jun; 113(6):2147-55. PubMed ID: 22307688
[TBL] [Abstract][Full Text] [Related]
7. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
10. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
11. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
12. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells.
Lee GA; Choi KC; Hwang KA
Environ Toxicol Pharmacol; 2017 Jan; 49():48-57. PubMed ID: 27902959
[TBL] [Abstract][Full Text] [Related]
14. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
[TBL] [Abstract][Full Text] [Related]
15. Histamine prevents radiation-induced mesenchymal changes in breast cancer cells.
Galarza TE; Mohamad NA; Táquez Delgado MA; Vedoya GM; Crescenti EJ; Bergoc RM; Martín GA; Cricco GP
Pharmacol Res; 2016 Sep; 111():731-739. PubMed ID: 27473821
[TBL] [Abstract][Full Text] [Related]
16. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
17. Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.
Zhao Y; Planas-Silva MD
Cancer Lett; 2009 Mar; 275(2):204-12. PubMed ID: 19026486
[TBL] [Abstract][Full Text] [Related]
18. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
19. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
20. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
